3 leading Analysts; and top management from 7 Sector Firms
examine this vital industry in this 36 page report from The Wall Street Transcript.
Order this Report
A Basket Approach to the Biotech Space Jason Kantor - RBC Capital Markets
A Close Look at Therapeutics Within Biotech Matthew Kaplan - Ladenburg Thalmann & Co.
An In-Depth Look at Biotech Stocks Jonathan Aschoff - Brean Murray, Carret & Co., LLC
CEO Interviews (average 2,500 words): top management from 7 Sector Firms examine the outlook for its company and its sector. Firms interviewed include: AEterna Zentaris, Inc., CardioGenics Holdings, Inc., Corcept Therapeutics, Inc., Depomed, Inc., Ligand Pharmaceuticals Inc., NBTY, Inc., and Schiff Nutrition International, Inc.
Topics covered: Clinical, Financial & Regulatory Risks To Drug Development - Easing Capital Markets - Managing Inherent Volatility - FDA Approval Process - Small- & Mid-Cap M&A Rally - Basket Investment Approach - Impact Of Health Care Reform - Therapeutic Cardiovascular Plays - Investable Trend In Antibody Technology
ORDER THIS REPORT NOW! CLICK HERE
Companies covered: Genentech/Roche (RHHBY); Medivation (MDVN); Seattle Genetics (SGEN); AEterna Zentaris (AEZS); Abbott (ABT); Alexion (ALXN); Amgen (AMGN); Antares Pharmaceuticals (AIS); Ardea (RDEA); Astellas (4503); AstraZeneca (AZN); Auxilium (AUXL); Biogen (BIIB); CardioGenics (CHNG); Celera (CRA); Celgene (CELG); Celldex (CLDX); Corcept (CORT); Cornerstone Therapeutics (CRTX); Cubist (CBST); Dendreon (DNDN); Depomed (DEPO); Facet (FACT); Genentech (DNA); Gilead (GILD); Glaxo (GSK); ImmunoGen (IMGN); Keryx (KERX); Ligand (LGND); Merck (MRK); NBTY (NTY); Nektar (NKTR); OSI Pharmaceuticals (OSIP); Pfizer (PFE); Pharmacyclics (PCYC); Pozen (POZN); Schiff Nutrition International (WNI); Teva Pharmaceuticals (TEVA); UCB (UCB); United Therapeutics (UTHR).
